USANA Health Sciences Reports Strong Third Quarter Growth; Raises Full-Year 2020 Net Sales and EPS Outlook

Go back to USANA Health Sciences Reports Strong Third Quarter Growth; Raises Full-Year 2020 Net Sales and EPS Outlook

USANA Health Sciences (USNA) Tops Q3 EPS by 19c, Updates FY Guidance

October 20, 2020 4:19 PM EDT

USANA Health Sciences (NYSE: USNA) reported Q3 EPS of $1.44, $0.19 better than the analyst estimate of $1.25. Revenue for the quarter came in at $298.5 million versus the consensus estimate of $277.26 million.

GUIDANCE:

USANA Health Sciences sees FY2020 EPS of $5.15-$5.45, versus the... More